142 related articles for article (PubMed ID: 23796671)
1. Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia.
Sharifi-Mood B; Alavi-Naini R; Metanat M; Mohammadi M; Shakeri A; Amjadi A
Trop Doct; 2013 Apr; 43(2):49-53. PubMed ID: 23796671
[TBL] [Abstract][Full Text] [Related]
2. High-dose methylprednisolone in children with Crimean-Congo haemorrhagic fever.
Dilber E; Cakir M; Erduran E; Koksal I; Bahat E; Mutlu M; Celtik AY; Okten A
Trop Doct; 2010 Jan; 40(1):27-30. PubMed ID: 20075424
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
4. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
6. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study.
Sharifi-Mood B; Metanat M; Ghorbani-Vaghei A; Fayyaz-Jahani F; Akrami E
Arch Iran Med; 2009 Mar; 12(2):151-3. PubMed ID: 19249885
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
[TBL] [Abstract][Full Text] [Related]
8. Crimean Congo-haemorrhagic fever treated with oral ribavirin.
Fisher-Hoch SP; Khan JA; Rehman S; Mirza S; Khurshid M; McCormick JB
Lancet; 1995 Aug; 346(8973):472-5. PubMed ID: 7637481
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
Izadi S; Salehi M
Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
11. Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean-Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis.
Arab-Bafrani Z; Jabbari A; Mostakhdem Hashemi M; Arabzadeh AM; Gilanipour A; Mousavi E
J Antimicrob Chemother; 2019 Dec; 74(12):3432-3439. PubMed ID: 31369086
[TBL] [Abstract][Full Text] [Related]
12. Do we really need ribavirin in the treatment of crimean-congo hemorrhagic Fever?
Kalın G; Metan G; Demiraslan H; Doganay M
J Chemother; 2014 Jun; 26(3):146-9. PubMed ID: 24091085
[TBL] [Abstract][Full Text] [Related]
13. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever.
Ozbey SB; Kader Ç; Erbay A; Ergönül Ö
Vector Borne Zoonotic Dis; 2014 Apr; 14(4):300-2. PubMed ID: 24689859
[TBL] [Abstract][Full Text] [Related]
14. Crimean Congo hemorrhagic fever in Hazara division.
Malik S; Diju IU; Naz F
J Ayub Med Coll Abbottabad; 2011; 23(2):90-2. PubMed ID: 24800352
[TBL] [Abstract][Full Text] [Related]
15. The treatment of crimean-congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma.
Erduran E; Bahadir A; Palanci N; Gedik Y
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e19-24. PubMed ID: 23018575
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
17. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience.
Ceylan B; Calıca A; Ak O; Akkoyunlu Y; Turhan V
Int J Infect Dis; 2013 Oct; 17(10):e799-801. PubMed ID: 23773242
[TBL] [Abstract][Full Text] [Related]
18. Crimean-Congo haemorrhagic fever in a Greek worker returning from Bulgaria, June 2018.
Papa A; Markatou F; Maltezou HC; Papadopoulou E; Terzi E; Ventouri S; Pervanidou D; Tsiodras S; Maltezos E
Euro Surveill; 2018 Aug; 23(35):. PubMed ID: 30180928
[TBL] [Abstract][Full Text] [Related]
19. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
